Next, using an in vitro analysis in human HCC cells, we demonstrate that indeed LECT2 expression and its protein levels reflect β-catenin activity and hence hypothesize that it may be a good biomarker for HCC with β-catenin activation. The gene discussed is LECT2; the disease is hepatocellular carcinoma.